Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 2,653

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

Open access
Walton, Clare, King, Rachel, Rechtman, Lindsay, Kaye, Wendy, Leray, Emmanuelle, Marrie, Ruth Ann, Robertson, Neil, La Rocca, Nicholas, Uitdehaag, Bernard, van der Mei, Ingrid, Wallin, Mitchell, Helme, Anne, Angood Napier, Ceri, Rijke, Nick, Baneke, Peer·2020·Multiple Sclerosis Journal

Abstract

Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. Objectives: The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. Methods: Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. Results: A total of 2.8 million people are estimated to live with MS worldwide (35.9 per 100,000 population). MS prevalence has increased in every world region since 2013 but gaps in prevalence estimates persist. The pooled incidence rate across 75 reporting countries is 2.1 per 100,000 persons/year, and the mean age of diagnosis is 32 years. Females are twice as likely to live with MS as males. Conclusions: The global prevalence of MS has risen since 2013, but good surveillance data is not universal. Action is needed by multiple stakeholders to close knowledge gaps.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1352458520970841

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 2

  1. Yamout B, 2020, Mult Scler J Exp Transl Clin, 6
  2. 10.3390/brainsci10050305 · doi:10.3390/brainsci10050305

Cited by

See all 2,653

Metadata

Authors
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P.
Venue
Multiple Sclerosis Journal
Published
2020-11-11
Volume
26
Issue
14
Pages
1816-1821
ISSN
  • 1352-4585 (ISSN-L)
  • 1477-0970
OpenAlex
W3099273656
Cited by
2,653
References
8
FWCI
135.63
Type
journal article
Language
en
Open access
hybrid
Funders
  • Biogen
  • Novartis
  • Vanneau Trust
  • Associazione Italiana Sclerosi Multipla
  • Multiple Sclerosis Society
  • Merck
  • Bristol-Myers Squibb
  • Sanofi
  • National Multiple Sclerosis Society
  • Roche

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. https://app.cochat.ai/papers/10.1177/1352458520970841
The paper
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458520970841

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.